Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: June 2008
-
By Donald Zuhn — For the past few months, Patent Docs has been following and reporting on biotech and pharma lobbying efforts. Our interest in this topic stems from the push by Congress over the past year to pass patent reform and follow-on biologics legislation, and corresponding efforts by corporations and organizations during…
-
By Kevin E. Noonan — On June 9, 2008, the University of Pittsburgh obtained a judgment correcting inventorship of U.S. Patent No. 6,777,231 under 35 U.S.C. § 256. The U.S. District Court for the Central District of California determined that several of the inventors, who had assigned their rights to the Regents of…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Eli Lilly and Company et al. v. APP Pharmaceuticals LLC1:08-cv-00384; filed June 25, 2008 in the District Court of Delaware Infringement of…
-
On June 20th, the Biotechnology Industry Organization (BIO) concluded its 2008 International Convention. More than 20,000 attendees from over 2,100 biotech companies, organizations, and institutions — including Patent Docs authors (and MBHB attorneys) Donald Zuhn, Sherri Oslick, and Kevin Noonan (below) — were in attendance at this year’s International Convention in San Diego. In addition…
-
July 1, 2008 – Prior Art & Obviousness 2008: The PTO and CAFC Perspective on Patent Law Sections 102 & 103 (Practising Law Institute) – New York, NY July 9, 2008 – Quanta v. LG: What You Should Know (ALI-ABA) – 12:00-1:00 PM (EST) webcast July 9-11, 2008 – Fundamentals of Patent Prosecution 2008: A…
-
By Kevin E. Noonan — In 2001, The Medicines Company failed to file a patent term extension application for its anticoagulant drug Angiomax® (bivalirudin) within the 60-day time limit set forth under 35 U.S.C. § 156(d)(1); the application was filed one day late. Since that time, there have been efforts to remedy this…
-
The American Law Institute and American Bar Association (ALI-ABA) will be offering a webcast entitled: "Quanta v. LG: What You Should Know" on July 9, 2008 from 12:00-1:00 PM (EST). The Honorable Susan G. Braden of the United States Court of Federal Claims, John W. Olivo, Jr. of Ward & Olivo, and B. Todd Patterson…
-
By Donald Zuhn — Last week, a panel of biopharma attorneys participated in a breakout session at the BIO International Convention to discuss the impact of the Supreme Court’s decision in KSR Int’l Co. v. Teleflex Inc. on biopharma patent prosecution and litigation. Participating in the panel, entitled "Biopharma IP Strategies in the…
-
By Christopher P. Singer — The U.S. Patent and Trademark Office sent out an e-Commerce update on June 26, 2008 that provided information regarding the release of enhancements to Private PAIR and Public PAIR, the indexing of request documents for the Patent Prosecution Highway (PPH), and access to design patent applications using the…
-
By Kevin E. Noonan — As reported by Patent Docs earlier this week, the U.S. Patent and Trademark Office took the podium at BIO 2008 last week in San Diego, in the person of Dr. George Elliott, a Director in Group 1600. Like his boss, John Doll, Director Elliott is a personable and…
Patent Docs 